Showing 81 - 100 of 129 results.
The cancer-directed surgical procedure performed during the initial course of treatment for cancer, as represented by a code.
The completion date of the hormone therapy administered during the initial course of treatment for cancer, expressed as DDMMYYYY.
The date on which a cancer-directed surgical procedure was performed during the course of treatment for cancer, expressed as DDMMYYYY.
The site or region which is the target of particular surgical or radiotherapy treatment, as represented by an ICD-10-AM code.
The start date of hormone therapy administered during the initial course of treatment for cancer, expressed as DDMMYYYY.
The response of the tumour at the completion of the course of treatment for cancer, as represented by a code.
The start date of immunotherapy administered during the course of treatment for cancer, expressed as DDMMYYYY.
The start date of the radiotherapy administered during the course of treatment for cancer, expressed as DDMMYYYY.
The date on which a systemic therapy procedure was administered during the initial course of treatment for cancer, expressed as...
The intention of the initial treatment for cancer for the particular patient, as represented by a code.
The surgical procedure used in the primary treatment of the cancer, as represented by a code.
The date on which the cancer-directed surgical treatment was performed.
The response of the tumour at the completion of the initial course of treatment for cancer, as represented by a...
An indicator of whether a patient's cancer treatment is discussed and a treatment plan developed by a multidisciplinary team, as...
The completion date of chemotherapy administered during treatment for cancer, expressed as DDMMYYYY.
The completion date of chemotherapy administered during the initial course of treatment for cancer, expressed as DDMMYYYY.
The start date of chemotherapy administered during the initial course of treatment for cancer, expressed as DDMMYYYY.
The eviQ protocol identifier for the systemic therapy agent protocol administered during the initial course of treatment for cancer.